Generics - Licensing


Current filters:


Popular Filters

1 to 25 of 45 results

Intrexon and Amneal in second product collaboration

Intrexon and Amneal in second product collaboration


US synthetic biology specialist Intrexon and privately-held generics drugmaker Amneal Pharmaceuticals…

Amneal PharmaceuticalsGenericsIntrexonLicensingProductionUSA

EPIRUS and Livzon Mabpharm to develop biosimilars for China

EPIRUS and Livzon Mabpharm to develop biosimilars for China


EPIRUS Biopharmaceuticals has signed a royalty-bearing, multi-product collaboration agreement with Livzon…

Anti-Arthritics/RheumaticsBiosimilarsBOW015ChinaEPIRUS BiopharmaceuticalsGastro-intestinalsGenericsLicensingLivzon MabpharmRemicadeResearch

Generics maker IGI Laboratories acquires 18 AstraZeneca drugs

Generics maker IGI Laboratories acquires 18 AstraZeneca drugs


New Jersey-based specialty generic company IGI Laboratories has acquired regulatory rights, related documents…

AstraZenecaGenericsIGI LaboratoriesLicensingUSA

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs


Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…


Medicines Patent Pool broadens collaboration with Gilead Sciences


The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Prasco to market authorized generic of NeoProfen Injection


Privately held US generic drugmaker Prasco Laboratories has entered into a distribution and supply agreement…

GenericsLicensingNeoProfenNeurologicalPrasco LaboratoriesRecordatiUSA

Grunenthal strengthens pain product portfolio with European rights to etoricoxib


Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

Prosonix and Mylan in deal for Flixotide and Flovent generics


Prosonix, a UK-based company which is developing a portfolio of inhaled “Respiratory Medicines by Design,”…

FloventGenericsGlaxoSmithKlineGlobalLicensingMylan LaboratoriesProsonixRespiratory and Pulmonary

Sandoz to commercialize Taiwan Liposome’s antifungal

Sandoz to commercialize Taiwan Liposome’s antifungal


Taipei-based biopharmaceutical company Taiwan Liposome Company has entered into a collaboration agreement…

Amphotericin BAntibiotics and Infectious diseasesAsia-PacificGenericsLicensingNovartisSandozTaiwan Liposome

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA


UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

Hikma in $40 million deal to enhance delivery of generic injectables


USA-based Unilife Corp has signed a long-term commercial supply contract with Jordan-headquartered Hikma…

GenericsHikma PharmaceuticalsLicensingMarkets & MarketingUnilife Corp

Acura Pharma settles with Par and Impax over Oxecta

Acura Pharma settles with Par and Impax over Oxecta


US specialty pharma firm Acura Pharmaceuticals saw its shares leap as much as 28% after it said that…

Acura PharmaceuticalsGenericsImpax LaboratoriesLicensingNeurologicalNorth AmericaOxectaPar PharmaceuticalPatents

Epic Pharma gets rights to sell 12 generics


Elite Pharmaceuticals (OTCBB: ELTP) has signed a manufacturing and license agreement with fellow USA-based,…

Epic PharmaGenericsLicensingNorth AmericaProduction

Baxter and Coherus in up to $246 million deal for biosimilar etanercept


US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

Biocad enters deal for exporting rituximab biosimilar to Turkey


Biocad, one of Russia's leading biotechnology companies, has signed a definitive agreement on the export…

BiocadBiotechnologyEuropeGenericsKocak FarmaLicensingMabTheraMarkets & MarketingOncologyRituxanrituximabRoche

Avanir agrees settlement with Sandoz over Nuedexta


US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Mylan strikes deal for Parkinson's disease drug Stalevo


US generics firm Mylan (Nasdaq: MYL) and Finland-based drugmaker Orion Corp (Nasdaq OMX Helsinki: ORNAV)…

GenericsLicensingMylan LaboratoriesNeurologicalNorth AmericaOrion CorpPharmaceuticalStalevo

US FTC will continue to challenge "anticompetitive" pharma pay-for-delay deals


The Federal Trade Commission told a Senate Judiciary subcommittee yesterday (July 23) that it will continue…

GenericsLegalLicensingMarkets & MarketingNorth AmericaPharmaceutical

Forest agrees another license deal for Bystolic


US drugmaker Forest Laboratories (NYSE:FRX) and Forest Laboratories Holdings have reached a settlement…

Amerigen PharmaceuticalsBystolicCardio-vascularForest LaboratoriesGenericsLicensingNorth AmericaPharmaceutical

Lupin to market MSD vaccine in India


US pharma giant Merck & Co (NYSE: MRK), known as MSD outside of North America, has entered into an India…


Actavis and Valeant to co-promote Zovirax and Cordran Tape


Valeant Pharmaceuticals International (TSX: VRX) entered into an agreement, effective immediately, for…

ActavisAnti-viralsCordran TapeGenericsLicensingMarkets & MarketingMylan LaboratoriesNorth AmericaValeant PharmaceuticalsZovirax Ointment

1 to 25 of 45 results

Back to top